Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_assertion description "[We assessed changes in the apoptosis-related genes BCL2, BAX, BCL2L12, FAS and CASPASE-3 in OVCAR-3 human ovarian cancer cells and BT-20 human breast cancer cells to provide an insight into the molecular mechanisms involved in the response of these cells to treatment with anticancer drugs and to assess their value as potential biomarkers of chemotherapy response in breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_assertion evidence source_evidence_literature NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_assertion SIO_000772 18783338 NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_assertion wasDerivedFrom befree-2016 NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_assertion wasGeneratedBy ECO_0000203 NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.
- befree-2016 importedOn "2016-02-19" NP692388.RAYcZ2sJHU6p3ywiFsw72mH_weG3qUyrKNesc83M6dnBM130_provenance.